Genmont Biotech Stock Last Dividend Paid
| 3164 Stock | TWD 20.40 0.10 0.49% |
GenMont Biotech fundamentals help investors to digest information that contributes to GenMont Biotech's financial success or failures. It also enables traders to predict the movement of GenMont Stock. The fundamental analysis module provides a way to measure GenMont Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GenMont Biotech stock.
GenMont |
GenMont Biotech Company Last Dividend Paid Analysis
GenMont Biotech's Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Current GenMont Biotech Last Dividend Paid | 1.1 |
Most of GenMont Biotech's fundamental indicators, such as Last Dividend Paid, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, GenMont Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
| Competition |
Based on the recorded statements, GenMont Biotech has a Last Dividend Paid of 1.1. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The last dividend paid for all Taiwan stocks is notably lower than that of the firm.
Did you try this?
Run Efficient Frontier Now
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. |
| All Next | Launch Module |
GenMont Fundamentals
| Return On Equity | 0.0535 | |||
| Return On Asset | 0.0289 | |||
| Profit Margin | 0.23 % | |||
| Operating Margin | 0.20 % | |||
| Current Valuation | 1.76 B | |||
| Shares Outstanding | 86.37 M | |||
| Shares Owned By Insiders | 37.09 % | |||
| Shares Owned By Institutions | 0.42 % | |||
| Price To Earning | 12.36 X | |||
| Price To Book | 1.58 X | |||
| Price To Sales | 5.47 X | |||
| Revenue | 427.93 M | |||
| Gross Profit | 299.33 M | |||
| EBITDA | 161.32 M | |||
| Net Income | 113.13 M | |||
| Cash And Equivalents | 999.04 M | |||
| Cash Per Share | 11.24 X | |||
| Total Debt | 34.08 M | |||
| Debt To Equity | 2.10 % | |||
| Current Ratio | 12.73 X | |||
| Book Value Per Share | 15.62 X | |||
| Cash Flow From Operations | 111.66 M | |||
| Earnings Per Share | 1.01 X | |||
| Target Price | 102.0 | |||
| Number Of Employees | 13 | |||
| Beta | 0.34 | |||
| Market Capitalization | 2.05 B | |||
| Total Asset | 1.7 B | |||
| Z Score | 36.0 | |||
| Annual Yield | 0.05 % | |||
| Net Asset | 1.7 B | |||
| Last Dividend Paid | 1.1 |
About GenMont Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GenMont Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GenMont Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GenMont Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for GenMont Stock Analysis
When running GenMont Biotech's price analysis, check to measure GenMont Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GenMont Biotech is operating at the current time. Most of GenMont Biotech's value examination focuses on studying past and present price action to predict the probability of GenMont Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GenMont Biotech's price. Additionally, you may evaluate how the addition of GenMont Biotech to your portfolios can decrease your overall portfolio volatility.